cyc 202 has been researched along with cvt 313 in 3 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (cvt 313) | Trials (cvt 313) | Recent Studies (post-2010) (cvt 313) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 19 | 0 | 11 |
| Protein | Taxonomy | cyc 202 (IC50) | cvt 313 (IC50) |
|---|---|---|---|
| Cyclin-T1 | Homo sapiens (human) | 2.3 | |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | 3.7 | |
| G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 3.7 | |
| Cyclin-A2 | Homo sapiens (human) | 0.22 | |
| G1/S-specific cyclin-E1 | Homo sapiens (human) | 0.176 | |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | 0.198 | |
| Cyclin-dependent kinase 7 | Homo sapiens (human) | 9.2 | |
| Cyclin-dependent kinase 9 | Homo sapiens (human) | 2.3 | |
| Cyclin-H | Homo sapiens (human) | 9.2 | |
| CDK-activating kinase assembly factor MAT1 | Homo sapiens (human) | 9.2 | |
| Cyclin-dependent-like kinase 5 | Homo sapiens (human) | 0.419 | |
| Cyclin-dependent kinase 5 activator 1 | Homo sapiens (human) | 0.419 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Matter, H; Naumann, T | 1 |
| Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
| Antony, T; Gore, S; Krishnamurthy, NR; More, SS; Nataraj, V; Pothuganti, M; Ramachandra, M; Talapati, SR | 1 |
3 other study(ies) available for cyc 202 and cvt 313
| Article | Year |
|---|---|
Structural classification of protein kinases using 3D molecular interaction field analysis of their ligand binding sites: target family landscapes.
Topics: Binding Sites; Crystallography, X-Ray; Cyclin-Dependent Kinases; Enzyme Inhibitors; Ligands; Models, Molecular; Molecular Structure; Purines; Quantitative Structure-Activity Relationship | 2002 |
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |
Structure of cyclin-dependent kinase 2 (CDK2) in complex with the specific and potent inhibitor CVT-313.
Topics: A549 Cells; Adenosine Triphosphate; Antineoplastic Agents; Binding Sites; Cell Proliferation; Cloning, Molecular; Crystallography, X-Ray; Cyclic N-Oxides; Cyclin-Dependent Kinase 2; Dose-Response Relationship, Drug; Escherichia coli; Gene Expression; Genetic Vectors; Humans; Indolizines; Models, Molecular; Protein Binding; Protein Conformation, alpha-Helical; Protein Conformation, beta-Strand; Protein Interaction Domains and Motifs; Protein Kinase Inhibitors; Purines; Pyridinium Compounds; Recombinant Proteins; Roscovitine | 2020 |